search
WhiteLab Genomics
Trends
- 1WhiteLab Genomics raises $26 million for AI gene therapy design▼AI helping to design the vehicles that could carry gene therapies into hard-to-reach cells, even in the brain? WhiteLab
WhiteLab Genomics has raised $26 million in Series B funding to use artificial intelligence in designing vectors, the vehicles that carry gene therapies into cells. The company is targeting a persistent problem in genetic medicine: a treatment can carry the right instructions but still fail to reach hard-to-access cells, including those in the brain.
- 2WhiteLab Genomics raises $26m for AI-designed genomic medicines▼WhiteLab Genomics raises $26m to advance AI-designed genomic medicines
WhiteLab Genomics has raised $26 million to advance its work on AI-designed genomic medicines. The Paris-based biotech uses artificial intelligence to speed up the design of gene and cell therapies, and the fresh funding will support development of its computational platform and drug pipeline. Observers see the deal as further proof that investors remain keen on AI applied to drug discovery.